With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2017||California|
|Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma||University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD||Reach Grants||2017||North Carolina|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression||University of Colorado Denver / Melanie Vincent, PhD||Young Investigator Grants||2016||Colorado|
|Targeting Fusion-driven Sarcomas||National Institutes of Health / Javed Khan, MD||Crazy 8 Pilots||2019||Maryland|
|Targeting Glutamine Addiction in Diffuse Intrinsic Pontine Gliomas (DIPGs)||University of Michigan / Sriram Venneti, MD/PhD||Innovation Grants||2018||Michigan|
|Targeting Glutamine Metabolism in MYC Driven Atypical Teratoid Rhabdoid Tumors||The Johns Hopkins University School of Medicine / Jeffrey Rubens, MD||Young Investigator Grants||2017||Maryland|
|Targeting HMGA1 in Childhood ALL||The Johns Hopkins University School of Medicine / Amy M. Belton, PhD||Young Investigator Grants||2011||Maryland|
|Targeting HMGA1 in Pediatric T-cell Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Joelle Hillion, PhD||Young Investigator Grants||2008||Maryland|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|